Mooren's Ulcer

Mooren’s ulcer (MU) is an inflammatory peripheral ulcerative keratopathy that occurs most commonly in the developing world. Recent evidence supports the notion that autoimmune mechanisms are involved in the pathogenesis of this disease. Patients with MU typically develop painful, progressive peripheral ulceration of the cornea that, if untreated, can lead to corneal perforation and blindness. Risk factors for the development of MU include HLA-DR17 haplotype expression, prior corneal surgery or trauma, and hookworm infestation. A thorough ocular and systemic history and clinical examination, together with directed laboratory testing, should be carried out to rule out other causes of corneal ulceration, including both infectious keratitis and peripheral ulcerative keratitis secondary to an underlying systemic autoimmune disease. Treatment of MU is often challenging, but typically includes local and/or systemic corticosteroids. Noncorticosteroid immunosuppressive agents, conjunctival resection or advancement and tectonic surgical repair have also been used with success in patients refractory to corticosteroid therapy.

[1]  Z. Wang,et al.  Mooren's ulcer in China: a study of clinical characteristics and treatment. , 2001, The British journal of ophthalmology.

[2]  J. Ladas,et al.  Systemic disorders associated with peripheral corneal ulceration , 2000, Current opinion in ophthalmology.

[3]  E. Cunningham,et al.  HLA and Mooren's ulceration , 2000, The British journal of ophthalmology.

[4]  A. Scott,et al.  Calgranulin C Has Filariacidal and Filariastatic Activity , 1999, Infection and Immunity.

[5]  M. Srinivasan,et al.  Mooren ulcer in South India: serology and clinical risk factors. , 1999, American journal of ophthalmology.

[6]  J. Hyams,et al.  Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease. , 1999, Clinical therapeutics.

[7]  J. Gottsch,et al.  Cytokine-induced calgranulin C expression in keratocytes. , 1999, Clinical immunology.

[8]  C. Foster,et al.  Vasculitic peripheral ulcerative keratitis. , 1999, Survey of ophthalmology.

[9]  J. Seino,et al.  Mooren's ulcer. , 1998, Optometry and vision science : official publication of the American Academy of Optometry.

[10]  R. Sundmacher,et al.  Ulkus Mooren - Vier schwere beidseitige Verläufe unter systemischer Ciclosporin-A-Therapie , 1997 .

[11]  R. Sundmacher,et al.  [Mooren ulcer. 4 severe bilateral disease courses with systemic cyclosporin A therapy]. , 1997, Klinische Monatsblatter fur Augenheilkunde.

[12]  J. Auran,et al.  Interferon treatment of Mooren's ulcers associated with hepatitis C. , 1995, American journal of ophthalmology.

[13]  Xiu-ying Jin,et al.  Immunological Analysis and Treatment of Mooren's Ulcer with Cyclosporin A Applied Topically , 1993, Cornea.

[14]  A. Thomson FK-506--how much potential? , 1989, Immunology today.

[15]  J. Stilma,et al.  Circulating antibodies against corneal epithelium and hookworm in patients with Mooren's ulcer from Sierra Leone. , 1983, The British journal of ophthalmology.

[16]  S. Leone.,et al.  Conjunctival excision or lamellar scleral autograft in 38 Mooren's ulcers from Sierra Leone. , 1983, The British journal of ophthalmology.

[17]  Trojan Hj [Aetiology and therapy of Mooren's ulcer (author's transl)]. , 1979 .

[18]  W. Green,et al.  Peripheral corneal degeneration and occlusive vasculitis in Wegener's granulomatosis. , 1978, American journal of ophthalmology.

[19]  R. Eiferman,et al.  IgE in limbal conjunctiva in Mooren's ulcer. , 1977, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[20]  S. I. Brown Mooren's ulcer. Treatment by conjunctival excision. , 1975, The British journal of ophthalmology.

[21]  Gnandoss As An analysis of ten cases of Mooren's ulcer. , 1974 .

[22]  B. Kietzman Mooren's ulcer in Nigeria. , 1968, American journal of ophthalmology.

[23]  E. T. Kuriakose Mooren's ulcer. Etiology and treatment. , 1963, American journal of ophthalmology.